Teleflex Incorporated (NYSE:TFX) Shares Purchased by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. boosted its stake in Teleflex Incorporated (NYSE:TFX - Free Report) by 1,401.5% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 41,726 shares of the medical technology company's stock after acquiring an additional 38,947 shares during the quarter. Robeco Institutional Asset Management B.V. owned 0.09% of Teleflex worth $7,426,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Janus Henderson Group PLC increased its stake in shares of Teleflex by 2.8% during the third quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company's stock worth $1,329,704,000 after purchasing an additional 147,147 shares in the last quarter. FMR LLC increased its stake in Teleflex by 70.1% during the 3rd quarter. FMR LLC now owns 269,490 shares of the medical technology company's stock worth $66,650,000 after buying an additional 111,086 shares in the last quarter. Assenagon Asset Management S.A. raised its holdings in shares of Teleflex by 457.6% during the third quarter. Assenagon Asset Management S.A. now owns 120,311 shares of the medical technology company's stock valued at $29,755,000 after acquiring an additional 98,735 shares during the last quarter. Point72 Asset Management L.P. lifted its position in shares of Teleflex by 31.2% in the third quarter. Point72 Asset Management L.P. now owns 407,442 shares of the medical technology company's stock valued at $100,768,000 after acquiring an additional 96,958 shares in the last quarter. Finally, Parkman Healthcare Partners LLC acquired a new stake in shares of Teleflex in the third quarter worth approximately $23,778,000. Hedge funds and other institutional investors own 95.62% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts recently commented on the company. Needham & Company LLC reissued a "hold" rating on shares of Teleflex in a research note on Monday, December 16th. Mizuho decreased their price target on shares of Teleflex from $275.00 to $250.00 and set a "neutral" rating on the stock in a research note on Friday, November 1st. Truist Financial cut their price target on Teleflex from $227.00 to $200.00 and set a "hold" rating for the company in a report on Wednesday, December 18th. Royal Bank of Canada dropped their target price on Teleflex from $275.00 to $245.00 and set an "outperform" rating for the company in a report on Friday, November 1st. Finally, StockNews.com upgraded shares of Teleflex from a "hold" rating to a "buy" rating in a report on Thursday, November 28th. Three equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Teleflex currently has an average rating of "Moderate Buy" and a consensus price target of $252.50.

Teleflex Trading Up 0.6 %

NYSE:TFX traded up $1.05 during trading hours on Wednesday, reaching $175.95. 416,025 shares of the stock were exchanged, compared to its average volume of 524,788. Teleflex Incorporated has a twelve month low of $171.69 and a twelve month high of $256.85. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The business has a 50-day moving average of $181.16 and a two-hundred day moving average of $212.13. The company has a market capitalization of $8.17 billion, a price-to-earnings ratio of 34.98, a PEG ratio of 1.78 and a beta of 1.16.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.